CIHR Rare Disease Research Initiative: Overview
The purpose of the CIHR Rare Disease Research Initiative is to support the rare disease ecosystem in Canada in the following areas:
- Catalyze the creation of a clinical network to streamline rare disease clinical research and facilitate the collaboration among researchers, patients, families, caregivers, health care providers, industry, and policy and regulatory bodies;
- Support research that will determine the best pathway to diagnose rare diseases by optimally positioning genomic testing in the diagnosis pathway;
- Support research to bridge the gap between model organisms/systems and clinical trials for rare disease drugs in Canada, ultimately increasing the capacity to bring gene therapies to clinic; and,
- Support research leading to better resource allocation and care for patients living with a rare disease.
- Date modified: